January 23, 2015

Reduced Gene Therapy-Related Risk

(The Scientist) – When treated with a gene therapy, a mouse model of methylmalonic acidemia—an uncommon metabolism deficiency—responds well. But although the mice’s metabolic problems, and their related untoward effects, are reduced, the animals end up with an increased risk … Read More

Posted by Bioethics Pundit

Posted in Genetic Ethics, News

Recommended Reading